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Abstract
Background: Bacterial DNA contamination in PCR reagents has been a long standing problem that hampers the adoption of
broad-range PCR in clinical and applied microbiology, particularly in detection of low abundance bacteria. Although several
DNA decontamination protocols have been reported, they all suffer from compromised PCR efficiency or detection limits. To
date, no satisfactory solution has been found.
Methodology/Principal Findings: We herein describe a method that solves this long standing problem by employing a
broad-range primer extension-PCR (PE-PCR) strategy that obviates the need for DNA decontamination. In this method, we
first devise a fusion probe having a 39-end complementary to the template bacterial sequence and a 59-end non-bacterial
tag sequence. We then hybridize the probes to template DNA, carry out primer extension and remove the excess probes
using an optimized enzyme mix of Klenow DNA polymerase and exonuclease I. This strategy allows the templates to be
distinguished from the PCR reagent contaminants and selectively amplified by PCR. To prove the concept, we spiked the
PCR reagents with Staphylococcus aureus genomic DNA and applied PE-PCR to amplify template bacterial DNA. The spiking
DNA neither interfered with template DNA amplification nor caused false positive of the reaction. Broad-range PE-PCR
amplification of the 16S rRNA gene was also validated and minute quantities of template DNA (10–100 fg) were detectable
without false positives. When adapting to real-time and high-resolution melting (HRM) analytical platforms, the unique
melting profiles for the PE-PCR product can be used as the molecular fingerprints to further identify individual bacterial
species.
Conclusions/Significance: Broad-range PE-PCR is simple, efficient, and completely obviates the need to decontaminate PCR
reagents. When coupling with real-time and HRM analyses, it offers a new avenue for bacterial species identification with a
limited source of bacterial DNA, making it suitable for use in clinical and applied microbiology laboratories.
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Introduction
Detection of bacterial DNA holds great promise as a rapid
diagnostic tool for early detection of bacterial infections, such as in
sepsis [1,2]. Numerous studies have demonstrated that, among
nucleic acid-based methods [3–7], broad-range PCR of the
conserved bacterial DNA sequences is selective enough to differen-
tiate bacterial from viral and other infections [8–10], pointing to the
great potential of broad-range PCR in clinical diagnostics of bacterial
infection. When coupling with high-resolution melting (HRM)
analysis, broad-range PCR can even identify bacteria at the species
level [11–13], offering a potentially revolutionizing diagnostic
platform that saves time and cost and improves diagnostic accuracy.
However, contamination and sensitivity issues have long frustrated
efforts to realize the potential of broad-range bacterial DNA
amplification in clinical microbiology [14,15]. In particular, bacterial
source DNA contamination in commercially available Taq DNA
polymerases has been a challenging problem that, to date, has no
satisfactory solution [16,17]. The contaminating DNA usually
include more than one strain or species that cannot be identified as
Thermus aquaticus or Escherichia coli but bear close homology to the
species of Pseudomonas fluorescens, Pseudomonas aeruginosa, Alcaligenes
faecalis,o rAzotobacter vinelandii [18]. Because conventional broad-range
PCR often co-amplifies these contaminants with the target bacterial
DNA, the consequent high false positive rate generally renders
accurate interpretation of the results difficult, if not impossible [19].
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20303In the past 20 years, many attempts have been tried to solve this
problem. Some examples include UV irradiation, restriction
endonuclease digestion, ultrafiltration, and pretreatment of
reagent with DNase I [20–23]. Unfortunately, all previous
attempts either failed to completely eliminate false positives due
to inherent limitations on reaction conditions or could not achieve
the required level of sensitivity due to apparent inhibition of the
PCR reaction [14,24]. As a result, many laboratories were forced
to resort to multiplex PCR or other non-PCR methods that are
usually difficult to optimize and perform [25–28].
Here we describe and demonstrate an innovative primer
extension PCR (PE-PCR) method capable of fully addressing the
problem of bacterial DNA contamination in PCR enzymes and
reagents. This method can be performed in a single-tube, is highly
reproducible, and has sufficient detection limit suitable for use in a
clinical and applied microbiology setting. When coupling with
real-time and HRM analysis, individual bacterial species can be
directly identified from their respective melting profiles without
resorting to multiplexing or hybridization probes. We believe that
PE-PCR and HRM analysis, together, form a novel molecular
diagnostic platform that can potentially revolutionize clinical
microbiology laboratory practices.
Results
Contamination issue in broad-range amplification of
bacterial DNA
Several ‘‘low-DNA’’ and HotStart Taq DNA polymerases are
available from commercial sources. As a starting point, we first
examined 4 commercially available low-DNA or HotStart Taq
DNA polymerases to see whether they are suitable for broad-range
amplification of bacterial DNA using the universal primer set
p201–p1370 [29]. Using these polymerases, we performed classical
PCR to amplify a sample containing 100 fg of representative
Staphylococcus aureus bacterial genomic DNA (equivalent to 20
copies of bacterial genome) and a ‘‘no template control (NTC)’’. A
significant amount of amplified DNA product was found in the
NTC reaction, rendering it indistinguishable from the sample
reaction (Fig. 1). This result confirms that commercially available
Taq DNA polymerase and PCR reagents are not sufficiently pure
for broad-range bacterial DNA detection in a clinical setting in
which detection limits at the fentogram level is usually required.
PE-PCR prevents co-amplification of contaminating DNA
Faced with the problem of contamination, all previous attempts
had focused on trying to further purify the reagents. This line of
thinking represents a frontal assault on the problem that
unfortunately turns out to be a futile exercise for the past 20
years. Thinking outside of the box, we sought an alternative route
of attack and came up with the PE-PCR strategy.
The PE-PCR strategy is an approach that combines primer
extension and PCRto circumvent the problem of endogenous DNA
contamination. As illustrated in Fig. 2, the key component of this
strategy is a fusion probe that comprises a bacterial sequence on its
39-end and a non-bacterial tag sequences on its 59-end. Using this
fusion probe as an extension primer, the PE-PCR reaction was
initiated by annealing an excess amount of the fusion probes to the
template bacterial DNA after heat-denaturing (Step 1 and 2). An
enzyme mix (EK mix) of exonuclease I (exo I) and Klenow DNA
polymerase was then added into the reaction mixture. As a result,
the unbound/free fusion probes were degraded by exo I and the
primer extension reaction was initiated by Klenow DNA polymer-
ase (Step 3a and 3b). Following heat-inactivation of EK mix, a
forward primer (non-bac-F) corresponding to the non-bacterial
sequence of the fusion probe and a reverse primer (bac-R) targeting
bacterial genomic sequence downstream of the fusion probe were
used forPCRamplificationofthe primer-extended product(Step4).
By tagging the template bacterial sequences witha non-bacterial tag
sequence prior to PCR amplification (Step 4), the templates are
distinguished from the contaminants contained in the PCR
reagents. In theory, our PE-PCR strategy should amplify only the
tagged template bacterial genomic DNA, thereby, rendering the
contaminants a non-issue (Step 5).
To provide a proof of principle, a serially diluted S. aureus
genomic DNA was subject to the PE-PCR strategy. The translation
elongation factor Tu (Tuf) gene of S. aureus was selected as the target
for PE-PCR amplification. A fusion probe (M13-TstaG422) was
designed with the M13 forward primer sequence at the 59-end and
the Tuf sequences (accession no. AF298796) at the 39-end (Table 1).
After annealing M13-TstaG422 to the template DNA, the EK mix
was added into the reaction to degrade the unbound fusion probe
and initiate primer extension. The primer extension product was
then subject to PCR amplification using M13 and the downstream
primer TstaG765 corresponding to the Tuf genomic sequences. As
a result, a 391-bp single PCR product was obtained with 50 fg of
bacterial DNA equivalent to 10 copies of S. aureus genome being
detectable by PE-PCR. Notably, no PCR product was observed in
the NTC control (Fig. 3A).
To mimic bacterial DNA contamination of PCR reagent and
enzyme, 100 fg of S. aureus genomic DNA was spiked into the EK
mix and the Taq DNA polymerase-PCR reaction mixture,
respectively. Significant amount of PE-PCR product was gener-
ated only when template bacterial DNA was present during primer
extension (Fig. 3B, lane 1). No PCR product was generated in the
NTC reaction (Fig. 3B, lane 5) or when PCR was performed in the
absence of M13 primer (Fig. 3B, lane 2). Remarkably, PE-PCR
facilitated amplification of template bacterial DNA without co-
amplifying the spiking bacterial DNA (Fig. 3B, lanes 3 and 4). The
presence of the spiking DNA in the EK mix or PCR reaction
mixture was verified by S. aureus species-specific PCR (Fig. 3B,
lanes 3 and 4, lower panel). These data indicate no interference
from the contaminating bacterial DNA in the PCR reagents and
enzymes on specific amplification of the template bacterial DNA
and provide a proof of principle for our PE-PCR strategy.
Figure 1. HotStart and low-DNA Taq DNA polymerases are not
sufficiently pure for sensitive and specific broad-range ampli-
fication of bacterial DNA. The genomic DNA (100 fg) of S. aureus
was amplified by HotStart or low-DNA Taq DNA polymerases (Taq #1:
Hot Start Taq DNA polymerase, Protech Inc.; Taq #2: Fast Hot Start Taq
DNA polymerase, KAPA Biosystems; Taq #3: Taq DNA polymerase,
TakaRa Inc.; Taq #4: ULTRATOOLS Taq DNA polymerase, Biotools Inc.)
using the primer set p201 and p1370 (lanes 1, 3, 5, and 7). Significant
amount of PCR product was present in the no template control
reactions (lanes 2, 4, 6, and 8).
doi:10.1371/journal.pone.0020303.g001
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quantities of bacterial DNA
To demonstrate the feasibility of PE-PCR in broad-range
amplification of bacterial DNA, we designed a universal fusion
probe M13-16S-p201F for broad-range PE-PCR of the 16S rRNA
gene that is highly conserved among various bacterial species.
Serially diluted S. aureus genomic DNA was subjected to broad-
range PE-PCR using the fusion probe M13-16S-p201F, the M13
forward primer, the p1370 reverse primer (Table 1), and a
routinely used HotStart Taq DNA polymerase (Protech) without
applying any decontamination pretreatment. A 237-bp single PCR
product was obtained with as little as 10 fg of template DNA
Figure 2. The principle of PE-PCR for bacterial DNA amplification and detection. A fusion probe is designed with the sequences at the 39-
end corresponding to the bacterial genomic sequences and a non-bacterial tag sequence at the 59-end. The reaction is initiated by annealing the
fusion probe to the template bacterial DNA after heat-denaturing at 95uC for 5 min (Step 1 and 2). An enzyme mix (EK mix) of exo I and Klenow DNA
polymerase is then added into the reaction mixture and incubated at 37uC for 2 h (Step 3a and 3b). Following heat-inactivation of EK mix at 80uC for
20 min (Step 3c), a forward primer (non-bac-F) corresponding to the non-bacterial sequence of the fusion probe and a reverse primer (bac-R)
targeting bacterial genomic sequence downstream of the fusion probe are used for PCR amplification of the primer extension product (Step 4). In this
setting, only template bacterial DNA but not the endogenous contaminated bacterial DNA is amplified (Step 5).
doi:10.1371/journal.pone.0020303.g002
Table 1. The primers and fusion probes sequences.
Primer/probe type Primer/probe name Sequences Amplicon
S. aureus tuf gene (accession number AF298796)
Fusion probe M13-TstaG422 59-CAGGGTTTTCCCAGTCACGAC GGCCGTGTTGAACGTGGT
CAAATC AAAGTTGG-39
391 bp
Forward primer M13 59-CAGGGTTTTCCCAGTCACGAC-39
Reverse primer TstaG765 59-TAACCATTTCAGTACCTTCTGGTAA-39
S. aureus-specific genomic DNA fragment (accession number AF033191)
Forward primer SA-F 59-AATCTTTGTCGGTACACGATATTCTTCACG-39 108 bp
Reverse primer SA-R 59-CGTAATGAGATTTCAGTAGATAATACAACA-39
Bacterial 16S rRNA gene
Fusion probe M13-16S-p201F 59-CAGGGTTTTCCCAGTCACGAC GAGGAAGGTGGGGATGA
CGTC AAATCATCATG-39
237 bp
Forward primer M13 59-CAGGGTTTTCCCAGTCACGAC-39
Reverse primer p1370 59-AGICCCGIGAACGTATTCAC-39
Forward primer p201 59-GAGGAAGGIGIGGAIGACGT-39
doi:10.1371/journal.pone.0020303.t001
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PE-PCR. No PCR product was observed in the NTC reaction
(Fig. 3C). Accordingly, the genomic DNAs from a number of
clinically important bacterial species have been tested and were
shown to be amplifiable by broad-range PE-PCR (data not
shown).
We also mimicked bacterial DNA contamination by spiking
100 fg of S. aureus genomic DNA into the EK mix and the Taq
DNA polymerase-PCR mixture, respectively. As expected, a
positive PE-PCR signal was obtained in the presence of 100 fg
template bacterial DNA (Fig. 3D, lane 1), whereas no PCR
product was generated in the artificially contaminating condition
and NTC reaction (Fig. 3D, lanes 2–4). Again, the presence of the
spiking DNA in the reaction mixture was verified by S. aureus
species-specific PCR (Fig. 3D, lower panel). These data together
proves that broad-range PE-PCR is capable of fully addressing the
problem of bacterial DNA contamination in PCR enzyme and
reagents.
To explore the detection limit of this strategy, different
concentrations of S. aureus genomic DNA ranging from 100 fg to
10 fg were subjected to broad-range PE-PCR. The probability of
obtaining a positive PCR signal for 100, 50, 25, and 10 fg of
template bacterial DNA was 100%, 95%, 65%, and 55%,
respectively (n=20). Hence, broad-range PE-PCR is easily
performed to specifically amplify template bacterial DNA without
compromising detection limit and specificity.
Broad-range real-time PE-PCR couples with HRMA for
bacterial species identification
To further enhance the power of this method, we modified the
protocol to incorporate real-time PCR and HRM analysis into the
broad-range PE-PCR platform. A 10-fold serially diluted S. aureus
genomic DNA (10 pg–10 fg) was subject to broad-range real-time
PE-PCR in the presence of HRM dye LCGreen I plus. As
revealed by the amplification plots, 10 fg of template DNA
resulted in amplicon-specific amplification and no PCR product in
the NTC reaction (Fig. 4A and 4B). The unique nucleotide
contents in the PCR amplicon of S. aureus produced a distinctive
derivative plot while no melting peak was observed for the NTC
reaction. The probability of obtaining a positive PCR signal for
100, 50, 25, and 10 fg of template DNA was 100%, 90%, 50%,
and 30%, respectively (n=10).
For comparison, PCR reagents were pretreated with DNase I
followed by broad-range PCR amplification of template S. aureus
genomic DNA using the primer pair p201 and p1370. As revealed
by the amplification and derivative plots (Fig. 4C), the addition of
DNase I significantly inhibited PCR amplification. At 1 U of
DNase I, the endogenous contaminating DNA was not completely
eliminated. Increasing the concentration of DNase I to 2.5 U
caused further PCR inhibition and hampered the detection limit fo
broad-range PCR amplification of bacterial DNA.
To further validate our strategy, we applied broad-range real-
time PE-PCR to analyze additional 12 common bacterial species
(Table 2) using 10-fold serially diluted genomic DNA (10 pg–
100 fg). The derivative plots and melting temperature from HRM
analyses of the PCR product easily distinguished most of the
bacterial species (Fig. 5 and Table 2) without sequencing of the
PCR amplicon.
Discussion
Bacterial DNA detection in a testing sample is crucial for
clinical, environmental and applied microbiology. Despite the
great potential of broad-range PCR of the conserved bacterial
DNA sequences as a molecular diagnostic tool [30,31], its
application has been hampered by the difficulty in removing
Figure 3. PE-PCR specifically amplifies template bacterial DNA without co-amplification of contaminating bacterial DNA. A. The
indicated amount of S. aureus genomic DNA was subjected to PE-PCR using the fusion probe M13-TstaG422 and the primer set M13 and TstaG765. B.
The S. aureus genomic DNA (100 fg) was subjected to PE-PCR (upper panel) as described in panel A (lane 1), in the absence of M13 primer (lane 2),
and in the artificially contaminating condition by adding 100 fg S. aureus genomic DNA into the EK mix (lane 3) or PCR mixtures (lane 4). PE-PCR was
also performed in the absence of template DNA (lane 5). The presence of S. aureus genomic DNA was confirmed by species-specific PCR that
amplified a chromosomal DNA fragment specific for S. aureus (lower panel). C. The indicated amount of S. aureus genomic DNA was used as the
template for broad-range PE-PCR using the fusion probe M13-16S-p201F and the primer set M13 and p1370. D. The S. aureus genomic DNA (100 fg)
was subject to broad-range PE-PCR (upper panel) as described in panel C (lane 1), and in the artificially contaminating condition by adding 100 fg of
S. aureus genomic DNA into the EK mix (lane 2) or PCR mixtures (lane 3). Broad-range PE-PCR was also performed in the absence of template DNA
(lane 4). The presence of S. aureus genomic DNA was confirmed by species-specific PCR to amplify a chromosomal DNA fragment of S. aureus (lower
panel). NTC, no template control.
doi:10.1371/journal.pone.0020303.g003
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and PCR reagents. The lack of reliable methods for decontam-
inating the PCR reagents has long challenged the field. The PE-
PCR technique we report in this study provides a simple and
elegant solution to this long standing problem and promises the
diagnostic potential of broad-range PCR detection.
Figure 4. Comparison of broad-range real-time PE-PCR and broad-range real-time PCR with DNase I pretreatment of PCR reagents.
A–C. The indicated amounts of S. aureus genomic DNA were subject to broad-range real-time PE-PCR using the fusion probe M13-16S-p201F and the
primer set M13 and p1370 in the presence of LCGreen I plus HRM dye (panel A and B). Alternatively, the PCR reaction mixtures with or without
pretreatment of DNase I (1 U and 2.5 U) were used for broad-range real-time PCR to amplify the indicated amounts of S. aureus genomic DNA (panel
C). The PCR product was subject to HRM analysis using HR-1 instrument. The amplification (panel A and left panel of C) and derivative plots (panel B
and right panel of C) were shown. NTC, no template control.
doi:10.1371/journal.pone.0020303.g004
Broad-Range PE-PCR for Bacterial DNA Detection
PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e20303Unlike previous attempts to solve the contamination problem,
our approach cleverly side-steps the problem by tagging the
templates with a non-bacterial sequence using a fusion probe for
primer extension. The key factors important to successful PE-
PCR hinges on the design of fusion probes and the appropriate
ratio of EK mix to ensure proper primer extension and removal
of unbound/free fusion probe. Our strategy offers several
advantages compared with previous methods. Most of the
previously reported methods are based on DNA degradation
strategy including the use of DNase I, UV irradiation,
exonuclease III and restriction endonuclease to eliminate
contaminating bacterial DNA [20–23,32–34]. Among these
methods, adding DNase I into the PCR enzyme mixes followed
by heat inactivation is the most classical and popular approach.
However, we and others noted that successful removal of
contaminants is dosage-dependent with respect to the amount
of DNase I [8,14]. The optimized working concentration of
DNase I varies between laboratories, is difficult to optimize, and
is usually in a narrow range [14]. The addition of DNase I also
has the undesirable effect on inhibition of PCR reaction. In
contrast, our strategy is designed to obviate the need for
decontamination. Because our strategy does not alter the PCR
reagents, it does not cause PCR inhibition or template DNA
degradation. Indeed, our data demonstrate that artificial
contamination by spiking bacterial DNA into the reagents or
Taq DNA polymerase does not affect PE-PCR-mediated
amplification of template bacterial DNA.
Moreover, our strategy does not result in any compromise of the
detection limit. In the case of bacteremia, it is estimated that
approximate 10–15 bacteria are present in 1 ml of patient blood
[35]. In practice, about 1–3 ml of blood are usually used as
starting material for molecular diagnostics of bacterial infection.
Therefore, a detection limit equivalent to about 100 fg or 20
copies of bacterial DNA is required. As found in our analysis (Fig. 3
and 4), the detection limit for broad-range PE-PCR can reach
10 fg (equivalent to 2 copies of bacterial DNA) with roughly 55%
of probability. At 100 fg, the probability of detection is 100%. This
level of sensitivity should be sufficient for detection of bacterial
infection in most clinical specimens.
With an eye towards actual clinical implementation, our broad-
range PE-PCR can be dovetailed with a variety of other analytical
methods to identify individual bacterial species. As an example, we
demonstrated the integration of the broad-range PE-PCR protocol
with real-time PCR and HRM analyses to form a complete
analytical platform for applications such as quantification of
pathogen load and/or species identification [11]. Similar to our
previous findings, HRM analyses of broad-range real-time PE-
PCR product results in distinguishable HRM profiles and
generates unique molecular fingerprints for various bacterial
species. In this study, the molecular fingerprints for 13 different
bacterial species have been established. These profiles can be
expanded further by including additional bacterial species. With a
comprehensive database of HRM profiles, identification of
bacterial species can be automated by scanning the molecular
fingerprint between the unknown sample and the standard in the
database. If required, heteroduplex formation or multiple PCR
fragments can be employed to distinguish the bacterial species with
closely similar HRM profile. These strategies have been reported
by a number of investigations for microorganism identification
[11–13,36–39] and add to the power of our broad-range PE-PCR.
In spite of the conceptual elegance and superior performance of
our strategy, there is still one potential weakness that may
potentially derail our method. During the step in which the fusion
probe is added, the templates are not yet tagged, hence, they are
not yet protected from the effects of contamination. Thus, care
must be taken in handling of the samples during the steps of probe
adding and primer annealing so to avoid contamination from the
working environment. Once the templates are tagged, the
contamination that occurs thereafter is not likely to cause a false
positive signal. This notion is supported by our data demonstrating
that no PCR product was observed in the artificial contamination
condition with bacterial DNA being spiked into the EK mix or
PCR reagents. Hence, PE-PCR greatly simplifies the procedure of
DNA decontamination and reduces the risk of contamination
during broad-range amplification of bacterial DNA.
Similar to other broad-range amplification techniques, species
identification by HRM analysis may be compromised by multiple
infections that account for 5%–22% of cases of bacteremia
Table 2. High-resolution melting profiles for clinically important bacterial species disclosed by broad-range PE-PCR of 16S rRNA
gene.
Bacterial species (n)
a Tm ± SD (6C) GC content (%) GenBank accession no.
S. sciuri (5) 85.0860.30 48.1 AB233332
S. epidermidis (3) 85.1560.31 48.1 L37605
S. aureus (5) 85.2560.31 48.5 Y15856
K. pneumoniae (3) 86.4260.27 52.3 AF511429
P. mirabilis (3) 86.6460.19 52.3 AF008582
C. koseri (5) 86.7160.21 52.7 EF059880
A. baumannii (3) 87.0060.11 54.9 AY738399
E. cloacae (6) 87.5660.21 54.0 DQ089673
E. coli (4) 87.6660.04 54.9 AF511430
E. cancerogenus (4) 87.7160.20 53.8 EF011116
E. faecalis (6) 87.8460.23 54.4 AB292313
P. aeruginosa (3) 87.9060.21 54.8 Z76672
A. enteropelogenes (3) 88.2660.04 54.8 EF465529
aNumber of test.
doi:10.1371/journal.pone.0020303.t002
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bacterial isolates are used for broad-range PCR amplification but
may limit the capability of PE-PCR for detecting multiple bacterial
species when PCR is performed directly with clinical specimens.
Nevertheless, the HRM parameters such as the presence of
multiple melting peaks in the derivative plot may provide
information for differentiating single vs. multiple infections in
clinical specimens. In addition, the combination of multiple
species-specific unlabeled probes [42] with HRM can be explored
for bacterial species identification when patients are co-infected
with multiple types of bacteria.
In conclusion, our PE-PCR based methods provide a turnkey
solution that solves the long standing problem of endogenous
bacterial DNA contamination. The broad-range PE-PCR is fast,
Figure 5. Broad-range real-time PE-PCR and HRM analysis for 12 different bacterial species. The indicated amounts of genomic DNA
from 12 different bacterial species were subject to broad-range real-time PE-PCR using the fusion probe M13-16S-p201F and the primer set M13 and
p1370 in the presence of LCGreen I plus. The PCR product was subject to HRM analysis using HR-1 instrument and the derivative plots were shown.
NTC, no template control.
doi:10.1371/journal.pone.0020303.g005
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conveniently combined with the commercially available bacterial
DNA extraction technique in an automated or semi-automated
fashion. Because broad-range PE-PCR renders the presence of
endogenous bacterial DNA in the PCR reagents and Taq DNA
polymerase a non-issue during PCR amplification of minute
sample DNA, this method can have a broader reach beyond
bacterial DNA amplification and detection. We fully expect that
the broad-range PE-PCR amplification system is also useful for
mycobacterium and fungi detection that encounters similar
challenge of reagent contamination [3]. When adapting to real-
time PCR and HRM platforms, this method provides a new
avenue for microbial identification in clinical and applied
microbiology laboratories.
Materials and Methods
Materials
The exo I and Klenow DNA polymerase were purchased from
New England Biolab (Ipswich, MA). The LCGreen I plus reagent
set and HR-1 instrument were purchased from Idaho Technology
(Salt Lake City, UT). The HotStart Taq DNA polymerase was
purchased from Protech (Taipei, Taiwan). The Fast Hot Start Taq
DNA polymerase was purchased from KAPA Biosystems
(Woburn, MA). The ‘‘low-DNA’’ Taq DNA polymerase was
purchased from Takara (Shiga, Japan). The ULTRATOOLS Taq
DNA polymerase was purchased from Biotools Inc. (Madrid,
Spain). The LightCycler capillaries were purchased from Roche
Applied Science (Indianapolis, IN). The DNase I was purchased
from Promega (Madison, WI). Bacterial strains were clinical
isolates as described previously [11]. A complete list of primer and
fusion probe sequences is shown in Table 1.
Isolation of bacterial genomic DNA
The overnight culture bacterial suspension (4 ml) was centri-
fuged at 10,000 rpm for 10 min and the pellet was resuspended in
4 ml of solution I buffer (25 mM Tris-HCl, pH 7.5, 50 mM
glucose, 10 mM EDTA, and 40 mg/ml lysostaphin). The bacterial
suspension was incubated at 37uC for 2 h and the reaction buffer
containing 280 ml of 20% SDS and 40 ml of proteinase K (10 mg/
ml) and RNase A (10 mg/ml) was added to the bacterial
suspension and incubated at 55uC overnight. After phenol/
chloroform extraction, supernatant was transferred to a clean
microcentrifuge tube, and the DNA was precipitated with ethanol.
After washing twice with 75% ethanol, DNA pellets were
resuspended in water for quantification and the subsequent PCR
assays.
PE-PCR
Conventional PE-PCR was performed within one reaction tube.
Briefly, the annealing step consisted of a 20 ml annealing mix
containing 8 mlo fH 2O, 5 ml of fusion probe (2 ng/ml), 5 mlo f
bacterial genomic DNA at the indicated concentration, and 2 mlo f
106 PCR buffer. The reaction mixture was heated to 95uC for
5 min and was kept at 37uC. Then 11 ml of EK mix consisting of
3 mlo fH 2O, 1 mlo f1 0 6PCR buffer, 5 ml of dNTP (2 mM), 1 ml
of Klenow DNA polymerase (5 U/ml), and 1 ml of exo I (20 U/ml)
was added to the annealing mix and incubated at 37uC for 2 h.
After heat inactivation at 80uC for 20 min, the reaction mixture
was brought up to 50 ml by adding 14 mlo fH 2O, 2 mlo f1 0 6PCR
buffer, 1 ml of forward primer M13 (5 mM), 1 ml of reverse primer
(5 mM), and 1 ml of HotStart Taq DNA polymerase (5 U/ml). The
PCR cycling condition was 1 cycle of 95uC for 10 min, 45 cycles of
95uC for 15 s, and 60uC for 1 min. For detection of spiking S.
aureus genomic DNA, the M13 and the reverse primer was
replaced by the primer set of SA-F and SA-R (Table 1) that
specifically amplifies S. aureus genomic DNA fragment [43].
For real-time PE-PCR, the reaction was proportionally scaled
down to 8 ml during binding of fusion probe and primer extension.
Then the reaction mixture was brought up to 20 ml by adding
1.5 mlo fH 2O, 2 mlo f1 0 6bovine serum albumin (BSA), 2 mlo f
106LCGreen I plus, 0.8 mlo f1 0 6PCR buffer, 0.4 ml of forward
primer M13 (5 mM), 0.4 ml of reverse primer (5 mM), and 0.5 mlo f
HotStart Taq DNA polymerase (5 U/ml) and was transferred to
the capillary tube. Real-time PCR was performed using Light-
Cycler 1.5 instrument and the cycling condition was 1 cycle of
95uC for 10 min, 45 cycles of 95uC for 15 s, and 60uC for 1 min at
a transition rate of 20uC/s.
High-resolution melting curve acquisition and analysis
Glass capillaries containing amplification products were trans-
ferred to the HR-1 instrument (Idaho Technology) and the PCR
fragments were melted at 64–96uC at a rate of 0.3uC/s. Melting
profiles such as the derivative plots and melting temperatures were
assessed with HR-1 software.
Pretreatment of DNase I for decontamination and broad-
range PCR amplification
The PCR reagents containing 2 mlo f1 0 6BSA, 2 ml of dNTP
(2 mM), 2 mlo f1 0 6 LCGreen I plus, 1 mlo f1 0 6 PCR buffer,
0.5 ml of HotStart Taq DNA polymerase (5 U/ml), were incubated
with DNase I (1 U or 2.5 U) at 37uC for 30 min. After heat
inactivation of DNase I at 85uC for 15 min, the reaction mixture
was brought up to 20 ml by adding 1 mlo f1 0 6PCR buffer, 2 mlo f
forward primer p201 (5 mM), 2 ml of reverse primer p1370 (5 mM),
and 5 ml of template DNA. The PCR cycling condition was 1 cycle
of 95uC for 10 min, 45 cycles of 95uC for 15 s, and 60uC for 1 min
at a transition rate of 20uC/s.
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